Abstract:Tumor is one of the most serious threats for human being. Although many anti-tumor drugs are approved for clinical use, the treatment outcome is still modest because of the poor tumor targeting efficiency and low accumulation in tumor. Therefore, it is important to deliver anti-tumor drug into tumor efficiently, elevate drug concentration in tumor tissues and reduce the drug distribution in normal tissues. And it has been one of the most attractive directions of pharmaceutical academy and industry. Many kinds of strategies, especially various nanoparticulated drug delivery systems, have been developed to address the critical points of complex tumor microenvironment, which are partially or mostly satisfied for tumor treatment. In this paper, we carefully reviewed the novel targeting delivery strategies developed in recent years. The most powerful method is passive targeting delivery based on the enhanced permeability and retention(EPR) effect, and most commercial nanomedicines are based on the EPR effect. However, the high permeability and retention require different particle sizes, thus several kinds of size-changeable nanoparticles are developed, such as size reducible particles and assemble particles, to satisfy the controversial requirement for particle size and enhance both tumor retention and penetration. Surface charge reversible nanoparticles also shows a high efficiency because the anionic charge in blood circulation and normal organs decrease the unintended internalization. The charge can change into positive in tumor microenvironment, facilitating drug uptake by tumor cells. Additionally, tumor microenvironment responsive drug release is important to decrease drug side effect, and many strategies are developed, such as p H sensitive release and enzyme sensitive release. Except the responsive nanoparticles, shaping tumor microenvironment could attenuate the barriers in drug delivery, for example, decreasing tumor collagen intensity and normalizing tumor microvessels to decrease the internal fluid pressure. All these strategies could enhance the accumulation and penetration of nanoparticles into tumor, leading to a homogenous distribution of drugs in tumor. To enhance the internalization by specific cells, active targeting delivery strategies are developed. There were many surface markers, receptors or carriers overexpressed on specific kinds of cells, thus the corresponding ligands were utilized to mediate active targeting to certain cells, including tumor cells, cancer stem cells, tumor neovasculatures, tumor associated macrophages and other tumor stroma cells. Targeting more than one cell type may provide an improved antitumor effect. Although these passive and active targeting strategies all have promising outcome in the treatment of tumor, some shortages are still unaddressed, such as the specificity of responsive is not good enough, and the active targeting may be diminished by the protein corona. Thus more research is required to promote the drug delivery study.

Strategies for deliveries of anti-cancer drugs from perspectives of a measurement theory and an adsorption theory

Self-assembled polymer nanostructures for delivery of anticancer therapeutics

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Structure-specific cleavage of the RNA primer from Okazaki fragments by calf thymus RNase HI.

Nanomaterials in Cancer-Therapy Drug Delivery System

[The Development of Novel Tumor Targeting Delivery Strategy].

Transport Cocktails for Cancer Therapeutics

Delivery Strategies for Macromolecular Drugs in Cancer Therapy

Advanced and Innovative Nano-Systems for Anticancer Targeted Drug Delivery

Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy

A Review Article on the Basic Concepts of Drug Delivery Systems as Targeting Agents

Supramolecular nanoparticle carriers self-assembled from cyclodextrin- and adamantane-functionalized polyacrylates for tumor-targeted drug delivery.

Dale's hypothesis revisited: different neuropeptides derived from a common prohormone are targeted to different processes.

Strategies to improve the EPR effect: A mechanistic perspective and clinical translation

Tumor-Targeted Drug Delivery With Aptamers

Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers

Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy

Size-Tunable Strategies for a Tumor Targeted Drug Delivery System

Near-Infrared-Controlled, Targeted Hydrophobic Drug-Delivery System for Synergistic Cancer Therapy

Multilayer Microcapsules As Anti-Cancer Drug Delivery Vehicle: Deposition, Sustained Release, and in Vitro Bioactivity

Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer